动脉瘤性蛛网膜下腔出血患者癫痫发作与动脉瘤治疗方式的相关性
本研究为单中心回顾性队列,纳入6年间282例动脉瘤性蛛网膜下腔出血(aSAH)患者,其中低级别(Hunt-Hess 1-3)203例(72.0%)、高级别(Hunt-Hess 4-5)79例(28%)。治疗方式为血管内栓塞194例(68.8%)或手术夹闭66例(23.4%)。18例(6.4%)出现癫痫,栓塞组10例(5.5%)与夹闭组7例(10.6%)比较p=0.15,无显著差异。低级别患者中癫痫发生率更低(p=0.016),且更多见于手术夹闭后(p=0.0089)。癫痫与ICU出院时更低的GCS相关(p<0.001),与随访时更高的mRS相关(p<0.001)。作者认为这些发现可能部分解释既往研究中栓塞患者结局更好的现象,并建议对夹闭后怀疑急性癫痫的低级别患者降低cEEG使用门槛。
要点
- 282例aSAH中18例(6.4%)出现新发癫痫,栓塞组10例(5.5%)vs夹闭组7例(10.6%),p=0.15,无显著差异。
- 低级别aSAH(Hunt-Hess 1-3)中癫痫发生率更低(p=0.016),且更多见于手术夹闭后(p=0.0089)。
- 癫痫与ICU出院时更低GCS相关(p<0.001),夹闭组p=0.011、栓塞组p<0.001、低级别组p<0.001。
- 癫痫与随访时更高mRS相关(p<0.001),夹闭组p=0.032、栓塞组p=0.004、低级别组p=0.003。
- 低级别患者接受栓塞治疗者未出现非惊厥性癫痫发作;作者建议对夹闭后怀疑急性癫痫的低级别患者降低cEEG使用门槛。
适用人群与场景
- 6年间单中心收治的全部aSAH患者,共282例;低级别(Hunt-Hess 1-3)203例(72.0%),高级别(Hunt-Hess 4-5)79例(28%)。
- 治疗方式为血管内栓塞194例(68.8%)或手术夹闭66例(23.4%)。
- 场景为ICU住院期间及门诊随访。
诊断标准与关键阈值
- 癫痫定义为 reviewing neurophysiologist 判定的任何观察到的临床癫痫发作或连续脑电图(cEEG)记录上的电graphic癫痫发作。
- 按Hunt-Hess分级分为低级别(1-3)和高级别(4-5)进行亚组分析。
研究设计与关键结果
- 研究类型为单中心回顾性队列,样本量282例,人群为aSAH患者,暴露为动脉瘤治疗方式(栓塞 vs 夹闭),主要观察新发癫痫与治疗方式的关系及与结局的关系。
- 癫痫总体发生率6.4%(18/282);栓塞组5.5%(10/194)vs夹闭组10.6%(7/66),p=0.15,无显著差异。
- 低级别患者中癫痫发生率更低(p=0.016),且更多见于手术夹闭后(p=0.0089)。
- 癫痫与ICU出院时更低GCS相关(p<0.001),夹闭组p=0.011、栓塞组p<0.001、低级别组p<0.001。
- 癫痫与随访时更高mRS相关(p<0.001),夹闭组p=0.032、栓塞组p=0.004、低级别组p=0.003。
- 低级别患者接受栓塞治疗者未出现非惊厥性癫痫发作。
证据类型、等级与局限
- 证据类型为单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现可能部分解释既往研究中栓塞患者结局更好的现象,并建议对夹闭后怀疑急性癫痫的低级别患者降低cEEG使用门槛。
- 低级别aSAH患者接受栓塞治疗者未出现非惊厥性癫痫发作,夹闭后癫痫更常见(p=0.0089),可影响对该人群癫痫监测的警惕性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Data on new-onset seizures after treatment of aneurysmal subarachnoid hemorrhage (aSAH) patients are limited and variable. We examined the association between new-onset seizures after aSAH and aneurysm treatment modality, as well their relationship with initial clinical severity of aSAH and outcomes.
METHODS: This is a retrospective cohort study of all aSAH patients admitted to our institution over a 6-year period. 'Seizures' were defined as any observed clinical seizure or electrographic seizure on continuous electroencephalogram (cEEG) recordings, as determined by the reviewing neurophysiologist. Subgroup analyses were performed in low-grade (Hunt-Hess 1-3) and high-grade (Hunt-Hess 4-5) patients. Outcomes measures were Glasgow Coma Score (GCS) at intensive care unit (ICU) discharge and modified Rankin Scale (mRS) at outpatient follow-up.
RESULTS: There were 282 patients with aSAH; 203 (72.0%) suffered low-grade and 79 (28%) high-grade aSAH. Patients were treated with endovascular coiling (N = 194, 68.8%) or surgical clipping (N = 66, 23.4%). Eighteen (6.4%) patients had seizures, of whom 10 (5.5%) had aneurysm coiling and 7 (10.6%) underwent clipping (p = 0.15). In low-grade patients, seizures occurred less frequently (p = 0.016) and were more common after surgical clipping (p = 0.0089). Seizures correlated with lower GCS upon ICU discharge (p < 0.001), in clipped (p = 0.011) and coiled (p < 0.001) patients and in low-grade aSAH (p < 0.001). Seizures correlated with higher mRS on follow-up (p < 0.001), in clipped (p = 0.032) and coiled (p = 0.004) patients and in low-grade aSAH (p = 0.003).
CONCLUSIONS: New-onset seizures after aSAH occurred infrequently, and their incidence after aneurysm clipping versus coiling was not significantly different. However, in low-grade patients, new seizures were more frequently associated with clipping than coiling. Additionally, non-convulsive seizures did not occur in low-grade patients treated with coiling. These findings may explain, in part, previous work suggesting better outcomes in coiled patients and encourage physicians to have a lower threshold for cEEG utilization in low-grade patients suspected to have acute seizures after surgical clipping.
参考来源
- Allen BB, Forgacs PB, Fakhar MA, et al. Association of Seizure Occurrence with Aneurysm Treatment Modality in Aneurysmal Subarachnoid Hemorrhage Patients. Neurocrit Care. 2018. PMID: 29484583. doi:10.1007/s12028-018-0506-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。